On Sunday, March 20, 2016 Hollis suffered significant headaches with double vision, nausea, and weakness. After a week of doctor visits, blood tests and a clean CT scan, an MRI on March 29th finally led doctors to discover a tumor on his brain stem called Diffuse Intrinsic Pontine Glioma (DIPG).

DIPG is a rare cancer, with only 350 children diagnosed in the United States each year. Average survival is one year from diagnosis. There is less than 1% survival rate 2 years from diagnosis

Hollis fought a 9 month battle, including 7 immunotherapy treatments in Cologne, Germany.  On January 2, 2017 he ran home to Heaven. His family has partnered with TGen,  Translational Genomics Research Institute, to fund ground breaking research towards finding a cure for DIPG.

Please consider joining them by donating to TGen.  Thank you for your show of support and love.

#HopeThroughHollis

DONATE

MAKE A DIFFERENCE, HELP FIGHT DIPG

What is DIPG?: diffuse intrinsic pontine glioma (dih-FYOOS in-TRIN-sik PON-teen glee-OH-muh)
A type of central nervous system tumor that forms from glial (supportive) tissue of the brain and spinal cord. DIPG usually occurs in children, forming in the brain stem.

Orders of $100 or more come with a free Hope Through Hollis drawstring backpack! Dismiss